Exploring the Seeds of Innovative Drug Discovery
Through Open Innovation
with Academic-Industrial Research Network

Forerunner Pharma Research (FPR) is a bio-pharmaceutical venture who strives to discover the seeds of innovative drug development by taking advantage of cutting edge biological technology. FPR was founded in April 2005, as a joint-venture by Chugai Pharmaceutical Co., Ltd. (Chugai), Mitsui & Co., Ltd., and the Central Institute for Experimental Animals. In October 2011, FPR became wholly owned subsidiary of Chugai.

FPR is pursuing academic-industrial collaborative research on genomic drug discovery at two laboratories, Yokohama Bio Industry Center.and Komaba Open Laboratory of Tokyo University. By integrating the fruits of the research together with Chugai’s proprietary drug discovery technology, FPR intends to develop new-generation of molecular targeted therapy, especially for cancer.

Drug discovery is a project that requires years of ceaseless efforts, even 10 years or longer.
FPR is committed to make a contribution to forward-looking drug discovery through realizing open innovation by further enhancing collaborative research network with domestic and oversea academic research institutes.

More about What we do